Please use this identifier to cite or link to this item:
Title: The role of matrix metalloproteinases (MMP) and their inhibitor in influenza A virus-induced host lung injury
Keywords: Matrix metalloproteinases, Influenza pneumonitis, Doxycycline, Gelatinases
Issue Date: 3-Jan-2011
Citation: NG HUEY HIAN (2011-01-03). The role of matrix metalloproteinases (MMP) and their inhibitor in influenza A virus-induced host lung injury. ScholarBank@NUS Repository.
Abstract: Acute respiratory distress syndrome (ARDS), a severe form of acute lung injury (ALI) is a major cause of death during influenza pneumonia. Our recent studies provide evidence for the involvement of recruited neutrophils, their toxic enzymes, such as myeloperoxidase and matrix metalloprotenases (MMPs) and neutrophil extracellular traps (NETs) in aggravating alveolar-capillary damage. In the present study, we investigated the effects of Doxycycline (DOX) treatment, an inhibitor of MMPs, on influenza-induced ALI. BALB/c female mice were infected with mouse-adapted influenza A/Aichi/2/68 (H3N2) virus and administered daily with 20 mg/kg or 60 mg/kg doxycycline orally. The effects of DOX on ALI were determined by measuring inflammation, capillary leakage and MMP-9 activities. Furthermore, levels of T1-a (membrane protein of alveolar type I epithelium) and thrombomodulin (endothelial protein) were evaluated by western blot analysis in the bronchoalveolar lavage fluid (BALF). Our results demonstrate significant reduction of inflammation and protein leakage in the lungs after DOX treatment. MMP-9 activity and levels of T1-a and thrombomodulin were also decreased in DOX-treated group. These results were corroborated with histopathology analysis, which demonstrated significant decrease in lung damage. Although DOX reduced ALI, there were no effects on virus titers and body weights. Taken together these results demonstrate that DOX can be a promising drug in alleviating ALI during influenza pneumonia. Further studies need to be tested to determine whether DOX can be used as a combination drug together with anti-viral agents to contain severe influenza pneumonia.
Appears in Collections:Master's Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
NgHH.pdf3.41 MBAdobe PDF



Page view(s)

checked on Oct 25, 2020


checked on Oct 25, 2020

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.